ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

CTMX CytomX Therapeutics Inc

4.63
0.13 (2.89%)
取引時間後
最終更新日: 06:45:56
15分遅延
名称 銘柄コード 市場 種別
CytomX Therapeutics Inc CTMX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.13 2.89% 4.63 06:45:56
始値 安値 高値 終値 前日終値
4.62 4.45 5.06 4.43 4.50
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0121:00GLOBECytomX Therapeutics to Report First Quarter 2024 Results and..
2024/4/0821:00GLOBECytomX Therapeutics Announces First Patient Dosed with..
2024/4/0321:00GLOBECytomX Therapeutics Announces Nomination of Second Clinical..
2024/3/2121:00GLOBECytomX Therapeutics Appoints Dr. Zhen Su to Board of..
2024/3/1821:00GLOBECytomX Therapeutics Announces Milestone Achievement in..
2024/3/1205:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/1205:10GLOBECytomX Therapeutics Reports 2023 Financial Results and..
2024/3/1205:02EDGAR2Form 8-K - Current report
2024/3/1205:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/1119:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
2024/3/0422:00GLOBECytomX Therapeutics to Report Fourth Quarter and Full Year..
2024/2/2722:00GLOBECytomX Therapeutics to Present at Upcoming March Investor..
2024/1/2422:00GLOBECytomX Therapeutics Announces FDA Clearance of IND..
2024/1/2010:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2010:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2010:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2010:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2010:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1222:00GLOBECytomX Therapeutics to Present at the B. Riley Securities..
2024/1/0422:00GLOBECytomX Therapeutics Outlines 2024 Company Priorities and..
2023/12/2306:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2306:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2306:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2122:00GLOBECytomX Therapeutics to Present at the 42nd Annual J.P...
2023/12/2009:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2009:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2009:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2009:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0806:15GLOBECytomX Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0806:05EDGAR2Form 8-K - Current report
2023/11/0806:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0121:00GLOBECytomX Therapeutics to Present at Upcoming November Investor..
2023/10/3121:00GLOBECytomX Therapeutics to Report Third Quarter 2023 Financial..
2023/10/3021:00GLOBECytomX Therapeutics to Present Preclinical Data for..
2023/10/1905:30GLOBECytomX Therapeutics Presents Preclinical Profile of..
2023/9/2308:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2308:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2308:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0605:05GLOBECytomX Therapeutics to Present at Upcoming September..
2023/8/2813:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/2505:05EDGAR2Form 8-K - Current report
2023/8/1610:40EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/1105:05GLOBECytomX Therapeutics to Present at the H.C. Wainwright Immune..
2023/8/0905:15GLOBECytomX Therapeutics Reports Second Quarter 2023 Financial..
2023/8/0905:08EDGAR2Form 8-K - Current report
2023/8/0905:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0121:00GLOBECytomX Therapeutics to Report Second Quarter 2023 Financial..
2023/7/2106:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2106:17EDGAR2Form 3 - Initial statement of beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock